Low Serological Prevalence of SARS-CoV-2 Antibodies in Cancer Patients at a German University Oncology Center

Conclusion In the present single center experience, a low serological prevalence of SARS-CoV-2 antibodies among cancer patients even after SARS-CoV-2 infection was found. The results support continued strict preventive measures as well as efforts towards faster vaccination, due to a low immunity level in the population.
Source: Oncology Research and Treatment - Category: Cancer & Oncology Source Type: research